RELINXIT

Pharmaceutical preparations; sanitary preparations for medical purposes; materials for dressings; pharmaceutical preparations for the prevention and treatment of human diseases; adjuvants for use with vaccines; clotting agent, clotting preparation; diagnostic preparations for clinical or medical laboratory use; natural polymers for use in general surgery; pharmaceutical preparation for use in halting blood flow and medical procedures, enuresis and blood disorders; plasmin inhibitor; preparations for use as a topical hemostat to control surgical bleeding, for the prophylaxis and treatment of bleeding complications, and to make alterations in tissue repair associated with certain blood clotting deficiencies; protein involved in the stabilization and strengthening of blood clots developed for the treatment of bleeding complications associated with congenital and acquired deficiencies; preparations which are used either locally/topically or systemically for hemostatic control